Aug 26, 2013, 08:00 AM by Michael Croft

Los Angeles Times | Amgen agreed to acquire Onyx Pharmaceuticals on Sunday for $10.4 billion. Amgen tried to acquire the in June for $120/share, but was rejected. Yesterday's agreement was for $125/share.

Aug 26, 2013, 08:00 AM by Michael Croft

Bio-IT World  | N-of-One Therapeutics has analyzed and interpreted its 4,000th cancer patient tumor, providing details on therapeutic options beyond the current standard of care in more than 70% of cases.

Aug 26, 2013, 08:00 AM by Michael Croft

The Huffington Post | Last week, the X Prize foundation canceled the $10-million Archon Genomics XPRIZE presented by Express Scripts.

Aug 22, 2013, 13:00 PM by Michael Croft

Bio-IT World | The Quanterix Corporation has launched its Simoa technology—SIngle MOlecule Array—making it commercially available for the first time on a fully automated platform for research use only.

Aug 22, 2013, 08:00 AM by Michael Croft

Bio-IT World | This past month, researchers from the Broad Institute released a software update to GenePattern, the Institute’s open-source genome sequence analysis software, which will allow programmers to upload their own analysis tools to an open database.

Aug 21, 2013, 11:00 AM by Michael Croft

Florida Union Tribune | The Center for Individualized Medicine at Mayo Clinic's Jacksonville campus received a personal $5 million gift to, "move from talking about the promise of genomic medicine to making it a reality for patients.”

Aug 21, 2013, 07:00 AM by Michael Croft

Bio-IT World | Last week, GenoSpace, PathGroup and Thomson Reuters announced an expansion of PathGroup’s SmartGenomics product to include Thomson Reuters’ information on genes, variants and therapeutic implications, and GenoSpace’s advanced analytical and information integration capabilities.

Aug 19, 2013, 11:05 AM by Michael Croft

Bio-IT World | Bina Technologies has launched two new capabilities making their big data genomics platform accessible to more users. Whole Exome Analysis and Bina On-Demand expand the user base for the company’s hardware appliance that quickly handles assembly and alignment of raw reads and variant calling in next generation sequencing.

Aug 19, 2013, 08:00 AM by Michael Croft

Aug 16, 2013, 11:00 AM by Michael Croft

Computerworld | Dell, in the midst of a privatization push by founder and CEO Michael Dell, reported a 72% profit drop yesterday.

Aug 16, 2013, 10:00 AM by Michael Croft

Aug 15, 2013, 12:00 PM by Michael Croft

Forbes | Regeneron Pharmaceuticals is ranked #4 on Forbes list of most innovative companies for their combination of smart science and smart business.

Aug 14, 2013, 08:00 AM by Michael Croft

Forbes | It's been a banner year for biotech IPOs--27 have gone public since January. Forbes breaks down who, when, and how much.

Aug 13, 2013, 09:00 AM by Michael Croft

Boston Globe | Bind Therapeutics filed an IPO registration yesterday, planning to raise $80.5 million. The company said it has already raised $94.7 million.

Aug 13, 2013, 08:00 AM by Michael Croft

Bio-IT World News Brief | Eric Perakslis has joined Precision for Medicine, Inc. as Senior Advisor, Bioinformatics and Information Technology. Precision is a specialized scientific services company formed in 2012 to support next generation medical products. The company is headquartered in Bethesda, Md with offices in Frederick, Md and Cambridge, Mass.

Aug 12, 2013, 12:00 PM by Michael Croft

Bio-IT World | Nimbus Data Systems has announced its fourth-generation all-flash arrays: the Gemini F400 and F600. Thomas Isakovich, CEO of Nimbus Data, tells Bio-IT World that the new offerings will mark a tide change in how widely flash is used, especially in technical computing sectors like the life sciences.

Aug 12, 2013, 10:00 AM by Michael Croft

Bio-IT World News Brief | GenoSpace, PathGroup and Thomson Reuters have launched an initiative to develop and deliver a best-in-class personalized medicine service for oncology.

Aug 12, 2013, 08:00 AM by Michael Croft

Forbes | A Forbes analysis finds that a company hoping to get a single drug to market can expect to have spent $350 million before the medicine is available for sale.

Aug 12, 2013, 08:00 AM by Michael Croft

CTOvision | Mark Guyer, deputy director of the NIH’s National Human Genome Research Institute (NHGRI), speaks with CTOvision about the big data centers of excellence, and the trends in data sharing.

Aug 12, 2013, 08:00 AM by Michael Croft

The Scientist | GNS Healthcare and Inova Translational Medicine Institute are collaborating to predict preterm birth. Using GNS's big data analytics platform and Invoa medical records, the groups hope to identify biomarkers that could predict early births.